Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy

World J Virol. 2015 Aug 12;4(3):285-94. doi: 10.5501/wjv.v4.i3.285.

Abstract

Human immunodeficiency virus (HIV) infection is a serious condition associated to severe immune dysfunction and immunodeficiency. Mechanisms involved in HIV-associated immune activation, inflammation and loss of CD4+ T cells have been extensively studied, including those concerning purinergic signaling pathways. Purinergic signaling components are involved in viral entry and replication and disease progression. Research involving the participation of purinergic signaling in HIV infection has been not only important to elucidate disease mechanisms but also to introduce new approaches to therapy. The involvement of purinergic signaling in the pathogenesis of HIV infection and its implications in the control of the HIV infection are reviewed in this paper.

Keywords: Human immunodeficiency virus; Immune activation; Inflammation; Purinergic signaling.

Publication types

  • Review